Shu-Gan-Liang-Xue Decoction, a Chinese herbal formula, down-regulates the expression of steroid sulfatase genes in human breast carcinoma MCF-7 cells

Journal of Ethnopharmacology

Volumn 127, Issue 3, 2010, Pages 620-624

  Zhang, Yi ^a,c   Li, Ping Ping ^b  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

^c BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Breast cancer; Estrogen biosynthesis; In vitro; Shu Gan Liang Xue Decoction; Steroid sulfatase

Indexed keywords

AGENTS AFFECTING METABOLISM; BUPLEURUM CHINENSIS EXRACT; CHINESE DRUG; CURCUMA WENYUJIN EXTRACT; LITHOSPERMUM EXTRACT; LUCIFERASE; MOUTAN RADICIS EXTRACT; PAEONIA ALBA EXTRACT; PLANT EXTRACT; SCHISANDRA CHINENSIS EXTRACT; SHU GAN LIANG XUE DECOCTION; STERYL SULFATASE; UNCLASSIFIED DRUG;

ARTICLE; BIOLUMINESCENCE; BREAST CARCINOMA; BUPLEURUM CHINENSIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CURCUMA WENYUJIN; DOWN REGULATION; DRUG MECHANISM; ENZYME ACTIVITY; ESTROGEN SYNTHESIS; HOT FLUSH; HUMAN; HUMAN CELL; MEDICINAL PLANT; MOUTAN RADICIS; NUCLEOTIDE SEQUENCE; PAEONIA ALBA; PLASMID; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSIENT TRANSFECTION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; DRUGS, CHINESE HERBAL; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; LUCIFERASES; PLANTS, MEDICINAL; PLASMIDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STERYL-SULFATASE;

EID: 76149123874     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2009.12.014     Document Type: Article

References (38)

1. Cancer C.G.O.H. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative group on hormonal factors in breast cancer. The Lancet 1997, 350:1047-1059.
2. Chetrite G.S., Pasqualini J.R. The selective estrogen enzyme modulator (SEEM) in breast cancer. The Journal of Steroid Biochemistry and Molecular Biology 2001, 76:95-104.
3. Evans T.R., Rowlands M.G., Luqmani Y.A., Chander S.K., Coombes R.C. Detection of breast cancer-associated estrone sulfatase in breast cancer biopsies and cell lines using polymerase chain reaction. The Journal of Steroid Biochemistry and Molecular Biology 1993, 46:195-201.
4. Henderson B.E., Ross R., Bernstein L. Estrogens as a cause of human cancer: the Richard and Hinda Rosenthal foundation award lecture. Cancer Research 1988, 48:246-253.
5. Hou Y., Guo T., Wu C., He X., Zhao M. Effect of shikonin on human breast cancer cells proliferation and apoptosis in vitro. Yakugaku Zasshi 2006, 126:1383-1386.
6. Hung J.Y., Yang C.J., Tsai Y.M., Huang H.W., Huang M.S. Antiproliferative activity of paeoniflorin is through cell cycle arrest and the Fas/Fas ligand-mediated apoptotic pathway in human non-small cell lung cancer A549 cells. Clinical and Experimental Pharmacology & Physiology 2008, 35:141-147.
7. Irahara N., Miyoshi Y., Taguchi T., Tamaki Y., Noguchi S. Quantitative analysis of aromatase, sulfatase and 17β-HSD1 mRNA expression in soft tissue metastases of breast cancer. Cancer Letters 2006, 243:23-31.
8. Jefcoate C.R., Liehr J.G., Santen R.J., Sutter T.R., Yager J.D., Yue W., Santner S.J., Tekmal R., Demers L., Pauley R., Naftolin F., Mor G., Berstein L. Tissue-specific synthesis and oxidative metabolism of estrogens. Journal of the National Cancer Institute. Monographs 2000, 27:95-112.
9. Li P.P. Effect of traditional Chinese medicine in improving hot flashes symptom of breast cancer. Chinese Journal of Integrative Medicine 2004, 10:166-167.
10. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods 2001, 25:402-408.
11. MacIndoe J.H. The hydrolysis of estrone sulfate and dehydroepiandrosterone sulfate by MCF-7 human breast cancer cells. Endocrinology 1988, 123:1281-1287.
12. Mocellin S., Rossi C.R., Pilati P., Nitti D., Marincola F.M. Quantitative real-time PCR: a powerful ally in cancer research. Trends in Molecular Medicine 2003, 9:189-195.
13. Nakata T., Takashima S., Shiotsu Y., Murakata C., Ishida H., Akinaga S., Li P.K., Sasano H., Suzuki T., Saeki T. Role of steroid sulfatase in local formation of estrogen in postmenopausal breast cancer patients. The Journal of Steroid Biochemistry and Molecular Biology 2003, 86:455-460.
14. Nussbaumer P., Billich A. Steroid sulfatase inhibitors. Medicinal Research Reviews 2004, 24:529-576.
15. Ozanne E.M., Klemp J.R., Esserman L.J. Breast cancer risk assessment and prevention: a framework for shared decision-making consultations. The Breast Journal 2006, 12:103-113.
16. Parkin D.M. International variation. Oncogene 2004, 23:6329-6340.
17. Pasqualini J.R., Chetrite G., Blacker C., Feinstein M.C., Delalonde L., Talbi M., Maloche C. Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer patients. Journal of Clinical Endocrinology and Metabolism 1996, 81:1460-1464.
18. Pasqualini J.R., Chetrite G.S. Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer. The Journal of Steroid Biochemistry and Molecular Biology 2005, 93:221-236.
19. Purohit A., Woo L.W., Chander S.K., Newman S.P., Ireson C., Ho Y., Grasso A., Leese M.P., Potter B.V., Reed M.J. Steroid sulfatase inhibitors for breast cancer therapy. The Journal of Steroid Biochemistry and Molecular Biology 2003, 86:423-432.
20. Purohit A., Woo L.W., Potter B.V., Reed M.J. In vivo inhibition of estrone sulfatase activity and growth of nitrosomethylurea-induced mammary tumors by 667 Coumate. Cancer Research 2000, 60:3394-3396.
21. Reed M.J., Purohit A., Woo L.W., Newman S.P., Potter B.V. Steroid sulfatase: molecular biology, regulation, and inhibition. Endocrine Reviews 2005, 26:171-202.
22. Russo I.H., Russo J. Role of hormones in mammary cancer initiation and progression. Journal of Mammary Gland Biology and Neoplasia 1998, 3:49-61.
23. Sasano H., Harada N. Intratumoral aromatase in human breast, endometrial, and ovarian malignancies. Endocrine Reviews 1998, 19:593-607.
24. Sasano H., Suzuki T., Nakata T., Moriya T. New development in intracrinology of breast carcinoma. Breast Cancer 2006, 13:129-136.
25. Singh F., Gao D., Lebwohl M.G., Wei H. Shikonin modulates cell proliferation by inhibiting epidermal growth factor receptor signaling in human epidermoid carcinoma cells. Cancer Letters 2003, 200:115-121.
26. Smith I.E., Dowsett M. Aromatase inhibitors in breast cancer. The New England Journal of Medicine 2003, 348:2431-2442.
27. Stanway S.J., Delavault P., Purohit A., Woo L.W., Thurieau C., Potter B.V., Reed M.J. Steroid sulfatase: a new target for the endocrine therapy of breast cancer. The Oncologist 2007, 12:370-374.
28. Stanway S.J., Purohit A., Woo L.W., Sufi S., Vigushin D., Ward R., Wilson R.H., Stanczyk F.Z., Dobbs N., Kulinskaya E., Elliott M., Potter B.V., Reed M.J., Coombes R.C. Phase I study of STX 64 (667 Coumate) in breast cancer patients: the first study of a steroid sulfatase inhibitor. Clinical Cancer Research 2006, 12:1585-1592.
29. Sun H., Xue D., Gao F., Ouyang T., Li P.P. Effect of shugan liangxue compound for relieving hot flashes in breast cancer patients. Zhongguo Zhong Xi Yi Jie He Za Zhi 2009, 29:30-33.
30. Suzuki T., Miki Y., Nakamura Y., Moriya T., Ito K., Ohuchi N., Sasano H. Sex steroid-producing enzymes in human breast cancer. Endocrine-Related Cancer 2005, 12:701-720.
31. Suzuki T., Nakata T., Miki Y., Kaneko C., Moriya T., Ishida T., Akinaga S., Hirakawa H., Kimura M., Sasano H. Estrogen sulfotransferase and steroid sulfatase in human breast carcinoma. Cancer Research 2003, 63:2762-2770.
32. Tanaka K., Kubushiro K., Iwamori Y., Okairi Y., Kiguchi K., Ishiwata I., Tsukazaki K., Nozawa S., Iwamori M. Estrogen sulfotransferase and sulfatase: roles in the regulation of estrogen activity in human uterine endometrial carcinomas. Cancer Science 2003, 94:871-876.
33. Wang W., Dai M., Zhu C., Zhang J., Lin L., Ding J., Duan W. Synthesis and biological activity of novel shikonin analogues. Bioorganic & Medicinal Chemistry Letters 2009, 19:735-737.
34. Wang W., Li P.P. The effects of herb lithospermum extract on MCF-7 cell and estrogen and progestogen levels in mice. Zhongguo Zhong Yao Za Zhi 2003, 28:1062-1067.
35. Wu C.X., Li P.P. Anti-tumor effect of Shu-Gan-Liang-Xue Decoction combined with tamoxifen on estrogen-dependent breast cancer. Chinese Journal of Experimental Traditional Medical Formulae 2008, 14:31-34.
36. Wu W. ERK signaling pathway is involved in p15INK4b/p16INK4a expression and HepG2 growth inhibition triggered by TPA and Saikosaponin a. Oncogene 2003, 22:955-963.
37. Zhang Y., Li P.P. Evaluation of estrogenic potential of Shu-Gan-Liang-Xue Decoction by dual-luciferase reporter based bioluminescent measurements in vitro. Journal of Ethnopharmacology 2009, 126:345-349.
38. Zhang Y., Qian R.Q., Li P.P. Shikonin, an ingredient of Lithospermum erythrorhizon, down-regulates the expression of steroid sulfatase genes in breast cancer cells. Cancer Letters 2009, 284:47-54.